Live Breaking News & Updates on Inhaled Formulation
Stay updated with breaking news from Inhaled formulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Relief and AdVita Close Definitive Agreement for Relief to Acquire All Outstanding Shares of AdVita dgap.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dgap.de Daily Mail and Mail on Sunday newspapers.
EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Takeover Relief and AdVita Close Definitive Agreement for Relief to Acquire All Outstanding Shares of AdVita 28.07.2021 / 07:00 Acquisition Expands Scope of Development of Inhaled Formulation of Aviptadil Geneva, Switzerland, July 28, 2021 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ( Relief ), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announced that it has closed a definitive agreement to acquire all outstanding shares of AdVita Lifescience GmbH ( AdVita ), a Germany-based, privately held pharmaceutical company developing effective products and strategies to improve the treatment and diagnosis of rare lung diseases. ....
Search jobs 20-Jan-2021 Relief and AdVita Sign Binding Term Sheet for Relief to Acquire All Shares of AdVita to Expand Scope of Development of Inhaled Formulation of Aviptadil EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Mergers & Acquisitions 20.01.2021 / 07:00 Relief and AdVita Sign Binding Term Sheet for Relief to Acquire All Shares of AdVita to Expand Scope of Development of Inhaled Formulation of Aviptadil Geneva, Switzerland, and Gundelfingen, Germany, January 20, 2021 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ( Relief ), a biopharmaceutical company with its lead compound RLF-100 TM (Aviptadil) in advanced clinical development to treat severe COVID-19 patients, and AdVita Lifescience GmbH ( ....